Introduction
The CACNA1A gene is located on the p region of chromosome 19 and encodes the a1 pore-forming subunit of the neuronal voltage-dependent calcium channel P/Q [1] . CACNA1A mutations underlie three disorders inherited in an autosomal dominant fashion: familial hemiplegic migraine type 1 (FHM1), episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6). FHM1 is a monogenic form of migraine characterized by the occurrence of motor deficits during the aura [2] . EA2 is characterized by paroxysmal attacks of ataxia associated with nausea, vomiting and ocular disturbances [2] . Conversely, SCA6 is a chronic disorder with progressive cerebellar ataxia [3] . P/Q channels are widely expressed in the central nervous system and are particularly abundant in Purkinje cells and cerebellar granules [1] . Pathological mutations of the CACNA1A gene result in different alterations of P/Q channel physiology. Point mutations predicting premature stop codons or aberrant splicing, as well as large rearrangements, usually result in a loss of function of the channel and are typically associated with EA2 [2] . FHM1 is usually caused by missense mutations with a gain of function effect on calcium currents [2] . Lastly, the small polyglutamine repeat expansions found in SCA6 do not directly affect the gating property but may rather have a cytotoxic effect through aberrant intracellular interactions [4] .
CACNA1A disorders may show a substantial phenotypic overlap, which is most evident in EA2 and FHM1. Migraine or episodic ataxia may co-occur in the same genotype [5, 6] and during the disease course a number of patients may develop chronic cerebellar signs [5, 7] . Several case reports also described non-motor manifestations, such as cognitive and behavioral symptoms [5, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] in both FHM1 and EA2 pedigrees. Nonetheless, studies in large case series are lacking and findings from formal neuropsychological testing are scarce.
In the present paper, the neuropsychiatric phenotype of CACNA1A disorders is reviewed by retrospectively analyzing a large cohort referred to the ataxia unit of the Department of Neurology of Innsbruck Medical University. Furthermore, the literature is reviewed and possible pathophysiological mechanisms and therapeutic implications are discussed.
Methods
Genetically confirmed CACNA1A cases were retrieved from the database of the ataxia outpatient clinic of the Department of Neurology of Innsbruck Medical University. The following information was collected through a retrospective chart review: genotype, neurological phenotype, in-depth assessment of motor and cognitive milestones, and psychiatric history. Findings from neuropsychological testing conducted in our department were also retrieved. The investigations were conducted in accordance with the Declaration of Helsinki on ethical principles for medical research involving human subjects. Patients and legal guardians gave their informed written consent to perform genetic testing. According to the local regulation (Innsbruck Medical University ethics committee), no ethics committee approval was required to perform retrospective data analysis.
For the literature review, clinical reports of cognitive and psychiatric symptoms were sought as well as neuropsychological test findings in CACNA1A disorders. Articles were selected from PubMed using the following keywords: CACNA1A, FHM-1, EA2, SCA6, cognition, developmental delay, mental retardation, psychiatric, and neuropsychological testing. The literature search was restricted to articles in English. Only reports of genetically confirmed cases were considered.
Results

Clinical report and neuropsychological findings
Forty-four genetically confirmed CACNA1A cases were identified in our database (15 FHM1, 16 EA2, 13 SCA6). Fourteen cases (eight FHM1, six EA2) have already been described in previous reports from our group (given in bold in Table 1 ) [15, [28] [29] [30] . In particular, in FHM1 and EA2 overlapping clinical features were observed. One-third of FHM1 patients experienced gait ataxia and dysarthria as ictal symptoms and 50% of EA2 patients had migraine during the attacks or occurring independently. Two SCA6 patients reported episodic symptoms, such as short lasting vertigo and instability, preceding the onset of the chronic cerebellar syndrome.
The history of early milestones was available for 10 patients [median age at first examination 22 years (range 1, 5-36)]. Seven of them had a developmental delay after a normal birth and perinatal period (four FHM1, three EA2). In two additional cases, delayed cognitive and motor milestones followed pregnancy and perinatal complications (for details see Table 1 ).
Information on school performance was available in 22 cases [median age at examination 35 years (range ]. Poor school performance was reported by eight patients (36%, three FHM1, five EA2), of whom seven attended a special course or received special education programs.
Psychiatric symptoms were diagnosed in eight patients [median age at examination 29 years (range 18-58); two FHM1, six EA2]. These included attention deficit hyperactivity disorder, psychosis, anxiety disorder and personality disorders (for details see Table 1 ).
Neuropsychological testing was performed in 23 patients (11 out of 15 FHM1, 10 out of 16 EA2, two out of 13 SCA6; see also All patients had chronic cerebellar signs and cerebellar atrophy at cerebral magnetic resonance imaging (except 5-I, who had no cerebellar atrophy or ataxia, but a nystagmus at clinical examination). Cerebellar atrophy was mild in most FHM1 and EA2 patients. The degree of atrophy generally correlated with the severity of ataxia, whilst no correlation with the severity of cognitive and behavioral symptoms was observed. In FHM1 and EA2 patients, atrophy was more pronounced or, in several cases, limited (10 out of 31 patients) to the vermis cerebelli.
Review of the literature
The PubMed search yielded 588 items. After eliminating non-pertinent results and articles in a language other than English, 58 relevant papers were selected. The majority of studies entailed findings from clinical examination and anamnesis in single or a few pedigrees. Thirteen papers reported findings from neuropsychological testing.
In episodic CACNA1A disorders, the most common finding was a developmental delay after a normal birth and an unremarkable neonatal period (25 FHM1 and 10 EA2 pedigrees, respectively) [5, 10, 11, 13, 14, 17, [19] [20] [21] [22] [23] [24] [26] [27] [28] [31] [32] [33] [34] [35] . Delayed motor milestones or mental retardation were usually observed in the offspring of patients previously diagnosed with EA2 or FHM1, before the onset of episodic symptoms. Learning disabilities have been observed in older children [5, 27, 36] as well as behavioral abnormalities consistent with attention deficit hyperactivity disorder or autistic spectrum disorders [21, 22, 26, 27] .
Very little information was available about adult patients with FHM1 and EA2. Apart from reports of our group [15, 29, 37] , only two other studies examined cognition in adult patients with episodic CACNA1A disorders. Altogether, cognitive deficits were described at neuropsychological testing in adult patients from three FHM1 [8, 9, 29, 37] and one EA2 pedigrees [15] . A 'mild cognitive deterioration' was described in a further FHM1 patient at neurological examination [18] . Deficits at neuropsychological testing applied to different memory domains, attention and visual abilities [9, 15, 29] . In one case, a cognitive deterioration appeared contemporary to the onset of cerebellar motor symptoms at the age of 49 and rapidly evolved in dementia [8] . Psychosis has been described in adult patients from two FHM1 [18, 38] and one EA2 pedigree [25] .
No genotype-phenotype correlation was evident. Indeed the mutations associated with cognitive features span over the entire CACNA1A gene (Fig. 3 , Table 2 ) .
In all reported cases chronic cerebellar signs at examination and/or imaging evidence of cerebellar atrophy were documented [8, 10, 11, 13, [15] [16] [17] [19] [20] [21] [22] [23] 26, 29, 34] .
Concerning SCA6, earlier studies reported intact cognition on the basis of clinical examination and anamnesis [39] [40] [41] . Eight studies examined cognitive functions in SCA6 by means of neuropsychological test batteries [42] [43] [44] [45] [46] [47] [48] [49] . The most frequent finding was a mild deficit in executive functions, whilst intelligence, memory and attention were largely spared. Findings from self-assessment of depression and anxiety were unremarkable [42, 45, 48] . No other major psychiatric features have been reported.
Discussion
In the present study, the neuropsychiatric phenotype of a large CACNA1A cohort is described and analogous findings from the literature are summarized. From these data, it emerges that (i) early developmental delay is common in episodic CACNA1A disorders, (ii) cognitive deficits persist in adult patients and (iii) cognitive and behavioral features occur in association with chronic cerebellar signs. An early developmental delay was observed in several FHM1 and EA2 genotypes, both in our cohort and in previous reports, and was usually noticed years before the occurrence of hemiplegic attacks or other episodic symptoms. In most reports a history of delayed milestones was documented in only one or a few members within a pedigree, typically in the youngest generation. This may result from observational bias, as the recall of early psychomotor milestones in adult patients is challenging. Indeed, in our charts clinical information about psychomotor milestones were available only in the youngest patients (median age at first examination 22 years). A careful history may reveal poor school performance later in childhood, as was seen in our cohort (e.g. Patient 1-II) and other cases reported in the literature [9, 15] . Learning difficulties were repeatedly described in older children, as well as behavioral abnormalities consistent with attention deficit hyperactivity disorder and autism spectrum disorders. Few reports investigated cognition in adult patients, but various abnormalities were found when formal neuropsychological testing was performed. In our cohort, neuropsychological deficits widely overlapped with history of developmental delay/poor school performance and psychiatric manifestations (Table 1) .
Recently, through whole exome sequencing, CAC-NA1A mutations have been identified as a pathological hit also in cases of combined mental retardation and cerebellar signs with no suggestive family history and no episodic symptoms [50, 51] . Another recent study on autosomal dominant ataxia showed a high prevalence of cognitive deficits, especially as early intellectual deficiency, in patients with conventional, not polyglutamine, CACNA1A mutations [52] . Moreover, CACNA1A has been implicated in the pathogenesis of novel pediatric syndromes with mental retardation due to deletions at 19p13:2-13 loci [22, [53] [54] [55] . All these findings indicate that cognitive and behavioral symptoms belong to CACNA1A spectrum disorders, and emphasize that in several cases they may even be the main phenotypic expression.
Cerebellar signs and/or cerebellar atrophy in imaging studies were found in virtually all FHM1 and EA2 patients who showed cognitive and psychiatric disturbances. Notably, in some cases with unremarkable findings at the first imaging assessment, cerebellar atrophy eventually appeared later in the course of the The presence of cognitive deficits at neuropsychological testing (NPT) is reported in the last column. In patient ID, Arabic numbers indicate the pedigree and Roman numbers the family member. Age at first examination is reported. NPT was not performed in children (3-VIII, 3-X) and in patients with severe psychiatric disease (2-I, 2-II). Patients in bold have already been described in a Mechtcheriakov et al.
Indelicato et al.
[28], c Nachbauer et al [15] .
disease [26, 27, 31, 32] . The cerebellum is involved not only in motor tasks but also in the modulation of higher-order function [56] . As the 'motor' cerebellum refines movement, the 'cognitive' cerebellum contributes to the tuning of cognitive processes and social behavior [57, 58] . Plasticity phenomena in the cerebellar cortex are believed to underlie this modulation. Indeed, the input signals conveyed by the climbing fibers can elicit a long-term depression of the synapses between parallel fibers and Purkinje cells and thus modulate the final output on deep cerebellar nuclei [59, 60] . Notably, synaptic plasticity in this network is driven by the activation of AMPA receptors, which in turn is coupled to calcium influx through the P/Q channels [61] . Cerebellar modulation may be particularly relevant during the early maturation of the central nervous system [62] . Accordingly, cognitive manifestations of cerebellar disorders are usually prominent in children, whilst they tend to be milder in cerebellar disorders with adult onset [57, [63] [64] [65] . Dysfunctions of the cerebellar circuitry are also assumed to play a crucial role in neuropsychiatric disorders with an early onset, such as autism spectrum disorders, attention deficit hyperactivity disorder and schizophrenia [66] [67] [68] [69] . The cognitive and behavioral alterations observed in CACNA1A disorders seem to mirror the spectrum of neuropsychiatric manifestations associated with cerebellar dysfunction, from a severe impairment, when signaling alterations occur in childhood, to less apparent but detectable deficits in the adult.
In our cohort, FHM1 and EA2 patients displayed a similar neuropsychological profile; this is of interest as these two disorders are generally associated with different alterations of P/Q channel kinetics. It can therefore be speculated that channel dysfunction solely, regardless of calcium current properties of the mutated channel (gain or loss of function), leads to neuropsychological disturbances in CACNA1A mutations. Notably, no major cognitive abnormalities have been described to date in SCA6 patients [44] . This finding may depend upon a different pathophysiology of the disorder. Indeed, SCA6 usually emerges in the fifth to sixth decade, i.e. after the complete maturation of the central nervous system [70] , and the polyglutamine expansions do not affect calcium currents [4] . The recognition of a neuropsychiatric phenotype in EA2 and FHM1 bears some relevant consequences Figure 2 Findings from neuropsychological testing. Findings from patients in bold have already been described (family 3 in Karner et al. [29] , family 4 in Nachbauer et al. [15] ). Light gray, slightly impaired (between 16th and 3rd percentile); dark gray, impaired (≤2nd percentile); p , normal findings; n.a., not administered. Patient 1-I had a Mini Mental State Examination of 10. for clinical management. Available pharmacological therapies such as flunarizine, a non-selective Ca 2+ -channel blocker, and acetazolamide, a carbonic anhydrase inhibitor, reduce the frequency and severity of neurological episodic manifestations, probably by modulating the gating properties of P/Q channels [71] . It could be argued that improvement of altered calcium signaling may bear a positive effect on plasticity phenomena within the cerebellum and in turn ameliorate neuropsychiatric features. A stabilization of both neurological symptoms and behavioral disturbances after treatment has occasionally been reported in adult patients [15] , but no further data are available. Concerning developmental issues in children, early support and treatment may be beneficial and possibly reduce the burden of later disabilities. Thus, affected parents should receive counseling and a systematic screening for developmental disorders should be performed in children with a positive family history.
In the present study, results were limited to a retrospective analysis and thus it was not possible to provide complete data on the entire cohort. The history of early milestones was available only in the youngest patients. Neuropsychological testing was not performed in the entire cohort. Children and patients with severe psychiatric disorders or overt dementia were not examined. Patients who underwent a different assessment protocol were not included in the present analysis. Moreover, not every patient received a complete test battery. Nonetheless, seven additional pedigrees with cognitive and behavioral features (pedigree 1, 5, 6, 7, 8, 9, 10; Table 1) are described and the most extensive characterization of the neuropsychiatric phenotype in CACNA1A disorder reported to date is provided. Prospective assessments are advocated to monitor the course of these symptoms and to evaluate the effect of early support and therapy. [5] 
